Youngjin Jang

Youngjin (Alvin) Jang is a Senior Scientist I at AbbVie since December 2020, following a role as a Postdoctoral Research Fellow in the Rovis Group at Columbia University in the City of New York from May 2019 to December 2020. Prior experience includes an internship at Xenon Pharmaceuticals Inc. in early 2013. Youngjin Jang earned a Doctor of Philosophy (Ph.D.) in Organic Chemistry from the University of Toronto between 2014 and 2019 and a Bachelor of Science (B.Sc.) in Chemistry from The University of British Columbia from 2009 to 2014.